Clinical Trials Logo

Clinical Trial Summary

A Multicenter Randomized Controlled Study on the Treatment of Refractory CTIT With Romiplostim N01 Compared to Recombinant Human Thrombopoietin


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06440824
Study type Interventional
Source Shandong University
Contact
Status Not yet recruiting
Phase Phase 3
Start date June 1, 2024
Completion date November 30, 2025